These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 12598410

  • 1. Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).
    Anderson CM, Mendoza ME, Kennedy DJ, Raldua D, Thwaites DT.
    Br J Pharmacol; 2003 Feb; 138(4):564-73. PubMed ID: 12598410
    [Abstract] [Full Text] [Related]

  • 2. Optimal absorptive transport of the dipeptide glycylsarcosine is dependent on functional Na+/H+ exchange activity.
    Kennedy DJ, Leibach FH, Ganapathy V, Thwaites DT.
    Pflugers Arch; 2002 Oct; 445(1):139-46. PubMed ID: 12397398
    [Abstract] [Full Text] [Related]

  • 3. Indirect regulation of the intestinal H+-coupled amino acid transporter hPAT1 (SLC36A1).
    Anderson CM, Thwaites DT.
    J Cell Physiol; 2005 Aug; 204(2):604-13. PubMed ID: 15754324
    [Abstract] [Full Text] [Related]

  • 4. H/dipeptide absorption across the human intestinal epithelium is controlled indirectly via a functional Na/H exchanger.
    Thwaites DT, Kennedy DJ, Raldua D, Anderson CM, Mendoza ME, Bladen CL, Simmons NL.
    Gastroenterology; 2002 May; 122(5):1322-33. PubMed ID: 11984519
    [Abstract] [Full Text] [Related]

  • 5. Epidermal growth factor and insulin short-term increase hPepT1-mediated glycylsarcosine uptake in Caco-2 cells.
    Nielsen CU, Amstrup J, Nielsen R, Steffansen B, Frokjaer S, Brodin B.
    Acta Physiol Scand; 2003 Jun; 178(2):139-48. PubMed ID: 12780388
    [Abstract] [Full Text] [Related]

  • 6. Activation of VPAC1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretion.
    Dérand R, Montoni A, Bulteau-Pignoux L, Janet T, Moreau B, Muller JM, Becq F.
    Br J Pharmacol; 2004 Feb; 141(4):698-708. PubMed ID: 14744818
    [Abstract] [Full Text] [Related]

  • 7. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S, Latini S, Barberi M, Teti A, Stefanini M, Canipari R.
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [Abstract] [Full Text] [Related]

  • 8. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 9. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S, Prisco M, Sciarrillo R, De Falco M, Capaldo A, Gay F, Andreuccetti P, Laforgia V, Varano L.
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [Abstract] [Full Text] [Related]

  • 10. Dual modes of 5-(N-ethyl-N-isopropyl)amiloride modulation of apical dipeptide uptake in the human small intestinal epithelial cell line Caco-2.
    Kennedy DJ, Raldua D, Thwaites DT.
    Cell Mol Life Sci; 2005 Jul; 62(14):1621-31. PubMed ID: 15968466
    [Abstract] [Full Text] [Related]

  • 11. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
    Anand BS, Patel J, Mitra AK.
    J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
    [Abstract] [Full Text] [Related]

  • 12. Regulation of intestinal hPepT1 (SLC15A1) activity by phosphodiesterase inhibitors is via inhibition of NHE3 (SLC9A3).
    Anderson CM, Thwaites DT.
    Biochim Biophys Acta; 2007 Jul; 1768(7):1822-9. PubMed ID: 17498647
    [Abstract] [Full Text] [Related]

  • 13. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
    García-Fernández MO, Collado B, Bodega G, Cortés J, Ruíz-Villaespesa A, Carmena MJ, Prieto JC.
    Gynecol Endocrinol; 2005 Jun; 20(6):327-33. PubMed ID: 16019382
    [Abstract] [Full Text] [Related]

  • 14. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O, Junicho A, Akashi T, Koizumi K, Matsuda T, Fuse H, Saiki I.
    Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
    [Abstract] [Full Text] [Related]

  • 15. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM, Goursaud S, Medja F, Lelièvre V, Mounien L, Husson I, Brabet P, Jégou S, Janet T, Gressens P.
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [Abstract] [Full Text] [Related]

  • 16. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Feb 01; 162(3):1707-16. PubMed ID: 9973433
    [Abstract] [Full Text] [Related]

  • 17. Calcium signal-mediated expression of the vasoactive intestinal polypeptide gene and its small contribution to activity-dependent survival of mouse cerebellar granule cells.
    Fukuchi M, Sakuragawa S, Tabuchi A, Tsuda M.
    J Neurosci Res; 2004 Jul 01; 77(1):26-34. PubMed ID: 15197736
    [Abstract] [Full Text] [Related]

  • 18. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
    Schulz S, Röcken C, Mawrin C, Weise W, Höllt V, Schulz S.
    Clin Cancer Res; 2004 Dec 15; 10(24):8235-42. PubMed ID: 15623599
    [Abstract] [Full Text] [Related]

  • 19. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Apr 15; 162(8):4685-96. PubMed ID: 10202009
    [Abstract] [Full Text] [Related]

  • 20. Basolateral glycylsarcosine (Gly-Sar) transport in Caco-2 cell monolayers is pH dependent.
    Berthelsen R, Nielsen CU, Brodin B.
    J Pharm Pharmacol; 2013 Jul 15; 65(7):970-9. PubMed ID: 23738724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.